2 December 2008
Microgen plc (the "Company")
Director/PDMR Shareholding
This notification is made in accordance with DR 3.1.4R (1) (a):
Microgen plc announces that, in accordance with the rules of the Microgen
Performance Share Plan 2006, awards of options over Ordinary Shares of 5p each
were made on 2 December 2008 to the following PDMRs:
Name of PDMR: Chris Beed
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 10,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 110,000
Name of PDMR: Tom Crawford
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 55,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 200,000
Name of PDMR: Clare Groom
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 30,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 200,000
Name of PDMR: Tamara Kahn
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 50,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 175,000
Name of PDMR: Philip Learmont
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 50,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 125,000
Name of PDMR: Martin Redington
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 20,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 200,000
Name of PDMR: Anjum Siddiqi
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 35,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 120,000
Name of PDMR: Elizabeth Sipiere
Date of Grant: 2 December 2008
Date on which it can be exercised: 2 December 2011
Total amount paid (if any) for grant of
option: NIL
Description of shares involved: 25,000 Ordinary Shares of 5p each
Exercise price in pence: 5p
Total Number of Shares over which
Options held following this notification: 200,000
If you require further information please contact:
A. Siddiqi, Company Secretary Tel: 01252 772 326
www.microgen.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.